• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[同种异体骨髓移植后的宿主-移植物相互作用;供体选择]

[Host-graft interactions after allogenic bone marrow transplantation; choice of donor].

作者信息

Alby N, Bernard A, Devergie A, Goldman J M, Hervé P, Maraninchi P, Raffoux C, Gluckman E

机构信息

Unité Fonctionnelle de Greffe de Moelle Osseuse, Hôpital Saint-Louis, France.

出版信息

Nouv Rev Fr Hematol (1978). 1988;30(1-2):55-64.

PMID:3290840
Abstract

The complexity of host-graft interactions after bone marrow transplantation explains the criteria of choice of the donor. Graft rejection, graft-versus-host disease, graft-versus-leukemia, delayed immune reconstitution, often associated or mutually exclusive are observed even with an HLA identical sibling donor. Syngeneic transplants may be complicated by leukemic relapse related to the loss of the graft-versus-leukemia effect. The compilation of files of unrelated donors increases the possibility of finding a matched unrelated donor. Preliminary results suggest that clinical results may be equivalent to those achieved with HLA identical sibling donors. Overall results of HLA mismatched transplants are disappointing because of the increase of immunological complications. Attempts at preventing graft-versus-host disease with T cell depletion led to an increase of immunological complications: rejection and leukemic relapse. Modifications of the conditioning regimen and use of in vivo monoclonal antibodies are currently being investigated. Ethical, legal, and psychological considerations have also to be taken into account in the donor choice especially with the increase of the donor pool.

摘要

骨髓移植后宿主与移植物相互作用的复杂性解释了供体选择的标准。即使是与受者HLA配型相同的同胞供体,也会出现移植物排斥、移植物抗宿主病、移植物抗白血病效应、免疫重建延迟等情况,这些情况常常相互关联或相互排斥。同基因移植可能因移植物抗白血病效应的丧失而并发白血病复发。无关供体档案的汇编增加了找到匹配的无关供体的可能性。初步结果表明,临床结果可能与HLA配型相同的同胞供体移植的结果相当。由于免疫并发症的增加,HLA配型不相合移植的总体结果令人失望。尝试通过去除T细胞来预防移植物抗宿主病导致免疫并发症增加:排斥反应和白血病复发。目前正在研究调整预处理方案和使用体内单克隆抗体。在选择供体时,尤其是随着供体库的扩大,伦理、法律和心理因素也必须考虑在内。

相似文献

1
[Host-graft interactions after allogenic bone marrow transplantation; choice of donor].[同种异体骨髓移植后的宿主-移植物相互作用;供体选择]
Nouv Rev Fr Hematol (1978). 1988;30(1-2):55-64.
2
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.来自基因分型 HLA 不相同的相关供体的 CD6+ T 细胞耗竭的异基因骨髓移植。
Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.
3
Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.在患有致命遗传性疾病(不包括严重联合免疫缺陷)的儿童中,采用来自基因上HLA不匹配供体的骨髓移植:使用两种单克隆抗体预防移植物排斥反应。
Pediatrics. 1996 Sep;98(3 Pt 1):420-8.
4
Allogeneic bone marrow transplantation: relation between chimaerism and immunity.异基因骨髓移植:嵌合体与免疫之间的关系。
Verh K Acad Geneeskd Belg. 1998;60(2):111-43; discussion 143-5.
5
Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia.40岁以上慢性粒细胞白血病患者的非亲缘异基因骨髓移植成功案例。
Biol Blood Marrow Transplant. 1998;4(1):3-12. doi: 10.1053/bbmt.1998.v4.pm9701386.
6
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.异基因反应性以及抗受体特异性产生白细胞介素2的辅助性T淋巴细胞前体细胞频率对骨髓移植后异基因反应性的预测价值。
Dan Med Bull. 2002 May;49(2):89-108.
7
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.联合器官与造血细胞移植后针对移植物抗宿主病和移植物排斥的保护性预处理。
Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10.
8
Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.来自不匹配的亲属和非亲属供体的骨髓移植治疗重型再生障碍性贫血。
Bone Marrow Transplant. 2006 Apr;37(7):641-9. doi: 10.1038/sj.bmt.1705299.
9
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.杀伤细胞免疫球蛋白样受体(KIR)配体不相容性对无关供者移植结局的影响:来自国际血液和骨髓移植研究中心、欧洲血液和骨髓移植登记处以及荷兰登记处的报告
Biol Blood Marrow Transplant. 2006 Aug;12(8):876-84. doi: 10.1016/j.bbmt.2006.05.007.
10
XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.XomaZyme-CD5免疫毒素联合部分T细胞清除用于预防匹配无关供者骨髓移植后的移植物排斥反应和移植物抗宿主病。
Bone Marrow Transplant. 1994 May;13(5):571-5.